单类药物:即将出现的一类治疗药物,用于调节癌症转移
Anurag Mathur1,2, Abha Meena1,2, Suaib Luqman1,2
1Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
Phytotherapy research : PTR
|December 16, 2023
概括
单类药物通过调节关键信号通路,有望预防癌症转移. 需要进一步的临床试验来确定它们作为抗癌剂的有效性.
科学领域:
- 自然产品 化学 化学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 来自芳香植物的单类植物具有多样化的生物活动.
- 广泛的研究强调了它们对抗癌症的抗增殖和亡作用.
- 单类药物的抗转移和抗血管性潜力需要进一步研究.
研究的目的:
- 审查特定单体类药物的抗转移和抗血管效应.
- 检查癌症转移中单类药物准的信号通路.
- 讨论单类药物在癌症治疗中的生物合成,分类和临床潜力.
主要方法:
- 关于单类药物和癌症转移的研究的文献综述.
- 分析涉及单胺中介抗癌效应的信号通路.
- 检查细胞系研究和有限的临床试验数据.
主要成果:
- 单类药物通过复杂的信号通路,如PI3K/AKT/mTOR和MAPK来调节转移.
- 它们会影响表皮-介质细胞转换 (EMT) 过程和血管内皮生长因子 (VEGF) 信号传递.
- 有证据表明,它可能对各种癌症细胞系产生抗瘤影响.
结论:
- 单类药物在抑制癌症转移方面表现出显著的潜力.
- 目前临床试验数据有限,这阻碍了它们作为抗癌药物的广泛应用.
- 正在探索先进的技术,以克服单类药物开发中的挑战.
更多相关视频
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


